# DIFLUPREDNATE
> **ANDA213774** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-01-26
## Drug
- **FDA Application Number:** ANDA213774
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIFLUPREDNATE
- **Generic name:** DIFLUPREDNATE OPHTHALMIC
- **Active ingredients:** DIFLUPREDNATE
- **Dosage form:** EMULSION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2026-01-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213774)
---
*AI Analytics · CC0 1.0*